Shares of Oxford Nanopore Technologies plc (LON:ONT - Get Free Report) traded down 10.2% during mid-day trading on Monday . The stock traded as low as GBX 127 ($1.59) and last traded at GBX 128.50 ($1.61). 3,354,197 shares were traded during mid-day trading, an increase of 54% from the average session volume of 2,182,529 shares. The stock had previously closed at GBX 143.10 ($1.79).
Several research analysts have weighed in on the company. JPMorgan Chase & Co. reaffirmed an "overweight" rating on shares of Oxford Nanopore Technologies in a research note on Friday, December 6th. Berenberg Bank reiterated a "buy" rating and issued a GBX 282 ($3.54) price objective on shares of Oxford Nanopore Technologies in a report on Tuesday, September 3rd. Finally, Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a GBX 190 ($2.38) target price on shares of Oxford Nanopore Technologies in a report on Wednesday, September 4th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus target price of GBX 235.50 ($2.95).
Read Our Latest Analysis on Oxford Nanopore Technologies
The firm has a 50 day moving average of GBX 142.50 and a two-hundred day moving average of GBX 129.78. The firm has a market capitalization of £1.21 billion, a price-to-earnings ratio of -642.50 and a beta of 0.80. The company has a quick ratio of 6.01, a current ratio of 4.45 and a debt-to-equity ratio of 8.07.
In other news, insider Gurdial (Gordon) Sanghera sold 1,993,571 shares of the business's stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of GBX 142 ($1.78), for a total value of £2,830,870.82 ($3,548,791.30). Insiders purchased 310 shares of company stock worth $45,010 over the last three months. Company insiders own 32.62% of the company's stock.
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Oxford Nanopore Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford Nanopore Technologies wasn't on the list.
While Oxford Nanopore Technologies currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.